<DOC>
	<DOCNO>NCT01470001</DOCNO>
	<brief_summary>This double-blind , randomize , control , parallel design ( n=140 ) study purpose measure efficacy Solifenacin 5mg treatment woman Post Void Dribbling ( PVD ) .</brief_summary>
	<brief_title>The Effect Solifenacin Post Void Dribbling Women</brief_title>
	<detailed_description>This investigation double-blind , randomize , control , parallel design % reduction PVD episodes ( event ) primary endpoint . Secondary endpoint include : 1 . The % patient least 50 % reduction PVD episodes . 2 . Patient 's perspective impact disease , capture use Pelvic Floor Distress Inventory ( PFDI ) , another questionnaire ask urinary symptom quality life . We compare Solifenacin 5 mg placebo . 140 subject enrol , 70 subject arm . The treatment group receive 5mg Solifenacin daily 12 week . Astellas Pharma supply drug placebo , prepackaged number . The Pharmaceutical Research Center ( PRC ) randomly assign subject treatment vs. placebo group blind subject investigator</detailed_description>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>1 . Women age 18 89 2 . Incontinence form post void dribble occurs least twice weekly . 1 . Severe renal hepatic disease . 2 . Active urinary tract infection . 3 . Glaucoma . 4 . Stress incontinence incontinence symptom 5 . Urge incontinence incontinence symptom 6 . Chronic severe constipation . 7 . History bladder cancer . 8 . Known suspected hypersensitivity anticholinergic . 9 . Any clinical condition would allow safe completion study . 10 . Pregnancy lactation , intention become pregnant study , use unreliable birth control method woman childbearing potential . Reliable form contraception include : permanent sterilization either partner , hormonal contraception ( oral contraceptive , Nuva ring , contraceptive patch , depoprovera , implant ) , intrauterine device ( IUD ) , condom . Abstinence consider reliable form contraception , abstinent subject inform need use condom form birth control mention become sexually active study . 11 . Presently systemic anticholinergic therapy therapy within last 4 week . Anticholinergic drug include ; darifenacin , fesoterodine , hyoscyamine , oxybutynin , solifenacin , tolterodine , trospium . 12 . Solid form potassium supplementation , present increase risk GI side effect .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>